قالب وردپرس درنا توس
Home / Health / Is it time to rethink the prescription restrictions on abortion drug Mifepriston? : Recordings

Is it time to rethink the prescription restrictions on abortion drug Mifepriston? : Recordings



Mifepristone is a medicine used to stop early pregnancies and relieve the symptoms of miscarriage. It is severely restricted by the FDA.

Adria Malcolm


Hide caption

Caption switch

Adria Malcolm

Mifepristone is a medication used to stop early pregnancies and relieve the symptoms of miscarriage. It is severely restricted by the FDA.

Adria Malcolm

Mifepristone is one of two medications approved by the Food and Drug Administration to help stop early pregnancy. It is also prescribed to reduce the severity of miscarriage symptoms. But it's heavily regulated in a way that can make it hard for women to get. In parallel with its approval in 2000, the FDA has restricted its use for safety reasons.

In a prospective article published this summer in the New England Journal of Medicine (19459025), former FDA Commissioner Dr. Dr. Helene Gayle believes that the Authority should re-examine whether such measures are still needed and should take into account recent studies that demonstrate that mifepristone is both effective and safe.

Henney, who was FDA commissioner when introducing the restrictions, stated that the agency placed mifepristone in its program for risky drugs, risk assessment and mitigation strategies. This program includes medicines like antipsychotics and narcotics. According to Henney, mifepristone is one of the most restricted drugs in the REMS program.

The FDA requires doctors and clinics to be certified for prescribing the drug and women need to go to a clinic, doctor's office or hospital to get it – rather than getting it in a pharmacy. In 2016, the Agency partially revised the restrictions to extend the gestational age of mifepristone and eliminate the need for personal follow-up after taking the medicine.